- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Daratumumab
Total 321 results
-
Janssen Research & Development, LLCCompleted
-
Seoul National University HospitalUnknownPlasmacytoma | Multiple Myeloma in Relapse | DaratumumabKorea, Republic of
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityCompleted
-
Merck Sharp & Dohme LLCWithdrawnMultiple MyelomaUnited States, Canada, France, Israel, Spain, Sweden
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Research & Development, LLCApproved for marketingMultiple MyelomaUnited States, United Kingdom, Spain, Brazil, Russian Federation, Japan
-
Grupo de Estudos Multicentricos em Onco-HematologiaUnknownMultiple Myeloma Stage IBrazil
-
City of Hope Medical CenterNational Cancer Institute (NCI)Withdrawn
-
Hellenic Society of HematologyTakeda; Janssen Pharmaceutica NVUnknown
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, Austria, Greece, Netherlands, Sweden
-
M.D. Anderson Cancer CenterJanssen Scientific Affairs, LLCWithdrawnMalignant Neoplasms Stated as Primary Lymphoid Haematopoietic
-
Janssen Research & Development, LLCTerminatedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-CellUnited States, Australia, France, Belgium, Turkey, Netherlands, Korea, Republic of
-
Janssen Research & Development, LLCCompleted
-
AbbVie (prior sponsor, Abbott)Completed
-
National University Hospital, SingaporeJanssen, LP; International Myeloma FoundationUnknownRelapse and / or Refractory MyelomaSingapore, Hong Kong, Taiwan, Korea, Republic of
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Netherlands, Sweden, Denmark
-
National University of Ireland, Galway, IrelandJanssen Pharmaceuticals; Cancer Trials IrelandUnknownMultiple MyelomaIreland
-
Hellenic Society of HematologyJanssen PharmaceuticalsUnknown
-
Vejle HospitalCompleted
-
Hospital Federal de BonsucessoCompleted
-
Janssen Pharmaceutical K.K.CompletedMultiple MyelomaJapan